ACADIA Pharmaceuticals (ACAD) News Today → What is Medicare Supplement Insurance? (From Tranzact) (Ad) Free ACAD Stock Alerts $16.71 +0.40 (+2.45%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineACADIA Pharmaceuticals (NASDAQ:ACAD) shareholders have endured a 37% loss from investing in the stock five years agofinance.yahoo.com - April 28 at 1:21 PMACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Given Average Recommendation of "Moderate Buy" by Brokeragesamericanbankingnews.com - April 27 at 4:28 AMACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Receives Consensus Rating of "Moderate Buy" from Analystsmarketbeat.com - April 27 at 4:28 AMAcadia Pharmaceuticals to Announce First Quarter Financial Results on May 8, 2024businesswire.com - April 24 at 4:05 PMFY2025 EPS Estimates for ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Decreased by Analystamericanbankingnews.com - April 24 at 2:56 AMACADIA Pharmaceuticals (NASDAQ:ACAD) Sets New 52-Week Low at $16.60marketbeat.com - April 23 at 5:56 PMFY2025 Earnings Forecast for ACADIA Pharmaceuticals Inc. Issued By Zacks Research (NASDAQ:ACAD)marketbeat.com - April 23 at 6:31 AMAcadia Pharmaceuticals Announces Trofinetide New Drug Submission for Treatment of Rett Syndrome Has Been Accepted for Filing and Priority Review by Health Canadabusinesswire.com - April 22 at 9:04 AMMutual of America Capital Management LLC Invests $2.21 Million in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)marketbeat.com - April 21 at 4:44 AMAcadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)businesswire.com - April 19 at 4:05 PMACADIA Pharmaceuticals (NASDAQ:ACAD) Reaches New 52-Week Low at $16.60americanbankingnews.com - April 18 at 4:50 AMAcadia Pharmaceuticals Presents New DAYBUE™ (trofinetide) Clinical Data at the 2024 American Academy of Neurology (AAN) Annual Meetingbusinesswire.com - April 17 at 4:05 PMACADIA Pharmaceuticals (NASDAQ:ACAD) Hits New 52-Week Low at $16.60marketbeat.com - April 16 at 11:02 AMAnalysts Offer Insights on Healthcare Companies: 4D Molecular Therapeutics (FDMT), Acadia Healthcare (ACHC) and Coherus Biosciences (CHRS)markets.businessinsider.com - April 15 at 8:57 AM3 Affordable Pharma Stocks to Buy for Portfolio Gainsstocknews.com - April 12 at 1:00 PMACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) to Post FY2026 Earnings of $1.42 Per Share, Leerink Partnrs Forecastsmarketbeat.com - April 12 at 6:56 AMAcadia Pharmaceuticals executive sells over $31,000 in company stockinvesting.com - April 11 at 11:18 PMAcadia Pharmaceuticals exec sells over $45k in stockinvesting.com - April 11 at 11:18 PM3 Pharma Stocks to Sell in April Before They Crash & Burninvestorplace.com - April 11 at 2:10 PMBuy Rating Justified by Vertex Pharmaceuticals’ Strategic Acquisitions and Promising Drug Pipelinemarkets.businessinsider.com - April 11 at 1:17 PMACADIA Pharmaceuticals Inc. to Post Q2 2024 Earnings of $0.17 Per Share, Leerink Partnrs Forecasts (NASDAQ:ACAD)marketbeat.com - April 11 at 7:11 AMCracking The Code: Understanding Analyst Reviews For ACADIA Pharmaceuticalsmarkets.businessinsider.com - April 10 at 5:01 PMACADIA Pharmaceuticals (NASDAQ:ACAD) Earns "Overweight" Rating from Cantor Fitzgeraldmarketbeat.com - April 10 at 10:25 AMACADIA Pharmaceuticals (NASDAQ:ACAD) Sets New 52-Week Low After Insider Sellingmarketbeat.com - April 10 at 10:24 AMACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Insider James Kihara Sells 1,790 Sharesinsidertrades.com - April 10 at 6:10 AMJames Kihara Sells 1,790 Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Stockmarketbeat.com - April 9 at 6:31 PMAnalysts Are Bullish on Top Healthcare Stocks: Harmony Biosciences Holdings (HRMY), Recursion Pharmaceuticals (RXRX)markets.businessinsider.com - April 9 at 10:57 AMACADIA Pharmaceuticals (NASDAQ:ACAD) Stock Rating Reaffirmed by Needham & Company LLCmarketbeat.com - April 9 at 8:30 AMAcadia Pharmaceuticals names new EVP of Research and Developmentinvesting.com - April 4 at 4:40 PMACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Given Average Recommendation of "Moderate Buy" by Analystsmarketbeat.com - April 2 at 4:22 AMAcadia Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conferencefinance.yahoo.com - April 1 at 6:26 PMBuy Rating Affirmed for Syros Pharmaceuticals Amid Promising Clinical Trials and Strategic Study Designsmarkets.businessinsider.com - April 1 at 1:26 PMInsider Selling: ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) COO Sells 5,140 Shares of Stockinsidertrades.com - March 29 at 6:44 AMVanguard Group Inc. Decreases Stock Holdings in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)marketbeat.com - March 29 at 4:18 AMThese Overlooked Mid-Cap Gems Are Ripe for a Rebounduk.investing.com - March 28 at 9:39 AMACADIA Pharmaceuticals Inc CEO Stephen Davis Sells 17,714 Sharesfinance.yahoo.com - March 28 at 9:39 AMACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) COO Brendan Teehan Sells 5,140 Sharesmarketbeat.com - March 27 at 9:29 PMACADIA Pharmaceuticals (NASDAQ:ACAD) Sets New 1-Year Low on Analyst Downgrademarketbeat.com - March 25 at 2:42 PMACADIA Pharmaceuticals (NASDAQ:ACAD) Price Target Cut to $25.00marketbeat.com - March 25 at 12:17 PMAnalysts Are Bullish on Top Healthcare Stocks: Immatics (IMTX), Vor Biopharma (VOR)markets.businessinsider.com - March 25 at 3:22 AMFY2024 EPS Estimates for ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Reduced by Zacks Researchmarketbeat.com - March 21 at 7:45 AM4 Cutting-Edge Pharma Stocks for Portfolio Diversificationstocknews.com - March 19 at 7:01 PMAnalysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS), Edwards Lifesciences (EW) and Aveanna Healthcare Holdings (AVAH)markets.businessinsider.com - March 18 at 1:54 PMAcadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)businesswire.com - March 15 at 4:05 PM3 Pharma Stocks to Sell in March Before They Crash & Burninvestorplace.com - March 14 at 6:49 PMGrabar Law Office Investigates Claims on Behalf of Shareholders of Acadia Pharmaceuticals Inc. (ACAD)markets.businessinsider.com - March 13 at 11:05 PMAcadia Pharmaceuticals to Participate in the UBS Virtual CNS Dayfinance.yahoo.com - March 13 at 6:04 PMEvaluating Acadia's Market Position Following Pimavanserin's Clinical Setbackseekingalpha.com - March 13 at 9:23 AMACADIA Pharmaceuticals Sinks After Schizophrenia Drug Failed In Late-stage Studymarkets.businessinsider.com - March 13 at 1:48 AMThese Stocks Are Moving the Most Today: Oracle, Acadia Pharmaceuticals, Vail Resorts, and Moremsn.com - March 13 at 1:48 AM Get ACADIA Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ACAD and its competitors with MarketBeat's FREE daily newsletter. Email Address What is Medicare Supplement Insurance? (Ad)Original Medicare helps covers a lot of hospital and medical services, but it still leaves some out- of- pocket medical costs to recipients. Make sure your family’s nest egg is protected from unpredictable medical expenses. Consider applying for a Medicare Supplement Insurance Plan that travels with you. Learn More Here ACAD Media Mentions By Week ACAD Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ACAD News Sentiment▼-0.170.33▲Average Medical News Sentiment ACAD News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ACAD Articles This Week▼116▲ACAD Articles Average Week Get ACADIA Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ACAD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: MoonLake Immunotherapeutics News MorphoSys News Evotec News Summit Therapeutics News IDEAYA Biosciences News Janux Therapeutics News Indivior News Arrowhead Pharmaceuticals News Crinetics Pharmaceuticals News Xenon Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ACAD) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHis win rate puts Warren Buffett to shame… Investing DailyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBiden out June 13; Kamala won’t replace him?Paradigm PressThe World's First "$20 Trillion Drug?"Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ACADIA Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
